Philanthropic Leaders Advance the New Medical/Surgical Pavilion with Commitment to Neurosciences

Washington, D.C.– Thanks to an inspiring multimillion-dollar philanthropic investment from the Bernstein Family, which includes Wilma and Stuart Bernstein, Richard Bernstein, Tracy and Adam Bernstein, and Lisa and Josh Bernstein and the Diane and Norman Bernstein Foundation, as well as Nancy and Marc Duber, who is executive vice president and chief operating officer of the Bernstein Companies real estate firm, the Medical/Surgical Pavilion at MedStar Georgetown University Hospital will be home to the Bernstein Family Patient Care Floor for Neuroscience Excellence.

Currently under construction, the facility’s design puts patient care and comfort at the forefront while promoting the very latest best practices in neurological care. Incorporating the most advanced medical technologies, the floor will be home to 52 patient beds in tranquil patient rooms, and both intensive care and intermediate care units.

“We are so very grateful to the Bernstein family for their generous gift, which will make a real and lasting impact for our patients and caregivers helping us to bring the world class care we deliver to a new world class, state-of-the-art facility,” says Michael C. Sachtleben, president of MedStar Georgetown University Hospital and a senior vice president for MedStar Health.

For former U.S. Ambassador Stuart Bernstein and Mrs. Bernstein, this partnership was motivated by gratitude for their personal experiences with two leading clinicians at MedStar Georgetown University Hospital. “At the Department of Neurology, my family experienced true excellence in care,” says Ambassador Bernstein. “Our philanthropic investment is intended to promote the life-changing work that MedStar Georgetown clinicians perform each day—and in doing so, to support the health and well-being of our community.”

As business and property owners in Georgetown, the Bernstein Family is especially excited to have the Hospital’s new Medical/Surgical Pavilion in their neighborhood. It will represent a new standard in how patients receive their care by offering private patient rooms, state-of-the-art operating rooms, a beautiful new green space to enhance the patient experience and compliment the healing environment, and a brand-new Emergency Department which will double in size and provide a more accessible, efficient and welcoming community resource for Georgetown residents and businesses.

One of the visionary partners, Mr. Duber, member of the board of directors and chair of the Philanthropy Committee at MedStar Health, along with his wife Nancy Duber, hope that this philanthropic investment will inspire others to partner with MedStar Georgetown. “The Medical/ Surgical Pavilion is an opportunity to support MedStar Georgetown at a pivotal moment in its long history,” says Marc Duber. “From growing our local health resources to facilitating broad-reaching research breakthroughs, this expansion is a cause worth cheering.”

To see more, including architectural renderings of the new pavilion, please visit MedStarGeorgetown.org/NewBuilding.

Media Contact

Debbie Asrate
Director of Media Relations
Office: 703-558-1287
[email protected]

MedStar Georgetown First and Only Center in the Washington, D.C. Metropolitan Region to Offer Proton Therapy for Cancer Patients

Dr. Brain Collins with MedStar Georgetown’s first patient to receive proton therapy.(Washington, D.C) April 17, 2018- For the first time, cancer patients in the Washington, D.C. metropolitan region have access to the latest cancer-fighting technology, proton radiation therapy, now available at the MedStar Georgetown University Hospital Proton Therapy Center.

Martha Ramos, 53 of Maryland became MedStar Georgetown’s first patient to receive proton therapy.  Ramos is being treated for recurrence of a brain tumor.  

“It’s encouraging to know that this kind of radiation will result in less damage to the healthy area of my brain,” says Ramos. 

Proton therapy is more precise and targeted than conventional radiation. It works by using pencil beam scanning, similar to a 3D printer, to match the tumor’s exact shape and size with superior accuracy that eliminates the exit dose of traditional radiation, and spares healthy tissue.

MedStar Georgetown is the first and only proton center in the world to offer the Mevion S250i with HYPERSCAN™ technology, producing beams that are sharper than previous proton systems. Proton therapy with HYPERSCAN is also faster than other proton systems, benefiting patients whose treatment includes holding their breath.

“I am extremely excited to be able to offer this latest advancement, proton therapy, to my patients,” says Brian Collins, MD, a radiation oncologist and clinical director of the new proton therapy center.  “It’s clear that this treatment will help to improve the clinical outcomes for our cancer patients and decrease their side effects when radiation is needed.”

 “In certain cases, proton therapy can be a game changer,” says Keith Unger, MD, radiation oncologist at MedStar Georgetown.  “It allows us to treat cancers where traditional radiation might not even be possible."

How Protons Destroy Cancer

“Proton therapy is an advanced form of radiation that can destroy cancer cells,” says Peter Ahn, MD, a radiation oncologist at MedStar Georgetown.  “A machine called a cyclotron speeds up protons to two thirds the speed of light and they become highly charged.  These high energy protons are then delivered to the tumor as an invisible beam that eradicates the cancer.  Because we can more tightly control the protons than we are able with traditional radiation, proton therapy can be given without damaging critical tissues and structures near the tumor because the beam conforms  precisely to the tumor’s size and shape, sparing healthy tissue.”

Advantages of HYPERSCAN™

HYPERSCAN is an FDA-approved proprietary technology that has advantages over existing proton therapy systems. In addition to producing a micro beam that is sharper than many current proton systems and reducing damage to nearby healthy tissue, HYPERSCAN is also faster than other pencil beam scanning systems which can reduce the margin of error in treating tumors that are affected by breathing or organ motion.  This improves both treatment accuracy and patient comfort as patients need to spend less time lying still.

“HYPERSCAN is currently the most precise type of proton therapy in the world,” says Dr. Ahn. 

“Proton therapy with HYPERSCAN can be given from head to toe,” says Dr. Collins.

Cancer Treatment for Patients with Fewer Side Effects

Proton therapy is beneficial for pediatric cancer patients because it lowers their exposure to radiation avoiding unnecessary exposure to healthy tissue and resulting in less growth impairment as they grow up.  Children are less likely to develop a secondary cancer later in life when treated with proton therapy as it treats tumors while keeping health surrounding tissues unharmed.

proton therapy patient with doctorProton therapy is also effective in treating re-current tumors.

 “There are also certain types of cancer where you have to deliver a very high dose of radiation right next to a critical structure like the spinal cord or brainstem,” says Sonali Rudra, MD, radiation oncologist at MedStar Georgetown. “With proton therapy we can deliver a high dose to the area we are trying to target and minimize the radiation beyond the tumor.  So for some patients, proton therapy might be their only radiation treatment option.”

“Proton therapy can also be a good option for patients with left-sided breast cancer, which is close to the heart,” says Dr. Rudra. “When indicated for breast cancer, using proton therapy instead of traditional radiation means more control over the radiation itself and less potential damage to the heart and lungs.”

Proton Therapy Closer to Home and Under One Roof

“The addition of proton therapy is a logical next step for a center like MedStar Georgetown as part of the Lombardi Comprehensive Cancer Center, dedicated to and recognized for providing the latest cancer treatments and access to clinical research trials,” says Dr. Collins.

Lombardi Comprehensive Cancer Center is one of only 49 sites in the nation and the only center in Washington, D.C. to earn the prestigious Comprehensive Cancer Center designation by the National Cancer Institute.

“All the multiple specialties and disciplines involved in cancer care are here helping to support patients through their treatment, in one location, under one roof,” says Dr. Unger. “They no longer have to travel outside of our area to receive this advanced treatment.”

 “The addition of proton therapy means MedStar Georgetown offers the full range of radiation treatments for cancer that are available,” says Dr. Collins.  “For patients that means we take an individual approach when considering radiation therapy. Whether it’s CyberKnife, proton therapy or conventional radiation, we will choose the optimal treatment to achieve the best outcomes with the fewest side effects.”

 

Media Contact

Marianne Worley
Director of Media Relations
Office: 703-558-1287
Pager: 202-405-2824
[email protected]

MedStar Georgetown First in the Nation Recognized for Excellence in Blood Management

National Certification Optimizes Care and Safety for Patients

Washington, D.C., March 30, 2017 -  MedStar Georgetown University Hospital is proud to become the first hospital in the United States to receive a prestigious distinction in recognition of excellence in patient blood management.

In a ceremony today at MedStar Georgetown, The Joint Commission and the AABB (formerly known as the American Association of Blood Banks) presented hospital representatives with the first Patient Blood Management Certification.

The certification provides a third party review and evaluation of patient blood management based on the AABB Standards for a Patient Blood Management Program, and an evidence-based approach to providing the best care to patients who might need transfusions. The Joint Commission is a national organization that accredits and certifies more than 21-thousand healthcare institutions and programs, nationwide.

“We at MedStar Georgetown University Hospital are very proud to be the first center in the nation to receive this important certification in Patient Blood Management from The Joint Commission and AABB, says Michael C. Sachtleben, president, MedStar Georgetown University Hospital. “This distinction is a testament to the hard work of our associates who promote patient safety through a comprehensive blood management program that uses internationally accepted systems and techniques. Our patients benefit from this innovative certification that recognizes our commitment to continuously improve our processes and procedures when it comes to patient-centered blood management and services. We thank the Joint Commission and the AABB for this program that will benefit patients nationwide.”

“We are proud to accept this distinction on behalf of our multi-disciplinary teams who work to promote quality care and patient safety through the use of practices that reduce risk by decreasing unnecessary transfusions, and improve patient outcomes,” says Lisa Boyle, MD, vice president of Medical Affairs at MedStar Georgetown. "This designation from The Joint Commission and the AABB demonstrates that our program has been evaluated to nationally recognized standards to benefit our patients."

One particular aspect of blood management at MedStar Georgetown is a Bloodless Medicine Program which is designed to eliminate blood transfusions altogether through the use of state of the art technologies that minimize blood loss and maximize the oxygen-carrying capabilities of blood during surgery and other medical treatments.
“Whether for religious or other reasons, our Bloodless Medicine and Surgery Program is state-of-the-art medical and surgical treatment without the use of blood transfusion,” says Mike Hofmann, coordinator, MedStar Georgetown’s Bloodless Medicine and Surgery Program. “Evidence from the treatment of this patient population has shown that bloodless medicine and surgery provides safe and effective alternatives to blood transfusion and holds the promise of a higher standard of care for all.”

The Patient Blood Management Certification is valid for two years.

Marianne Worley
Director of Media Relations
Office: 703-558-1287
Pager: 202-405-2824
[email protected]

Transplant Patient Starts off New Year with a Better Night’s Sleep and Gratitude for NPR Listeners after National Broadcast

Creasey being interviewedMedStar Georgetown kidney transplant recipient Constance Creasey learned about the kindness of strangers after a national radio broadcast featured her story, along with an interview with Dr. Matthew Cooper, MD, medical director of the Kidney Pancreas Transplant program at the MedStar Georgetown Transplant Institute.

NPR national medical correspondent Richard Harris compiled a story about Medicare coverage of anti-rejection drugs that expires after three years, but continues to pay for dialysis and even a new transplant. Dr. Cooper commented that this is a policy he believes needs to change.

To add patient perspective NPR interviewed Creasey, age 60 of Washington, D.C. who mentioned that sleeping on a bed is a luxury she can’t afford because she has to save money for her anti-rejection medications. When NPR’s Morning Edition  listeners heard the story on December 22, many wanted to donate and began to contact NPR and MGUH Media Relations to find out how.

A woman from Virginia bought Creasey a bed right after the holidays, while donated gift cards from all over the country provided her with sheets and blankets. Another woman from Illinois started a funding page for Creasey; some listeners donated to the MGTI's patient assistance fund that helps patients like Creasey in similar situations.  

“I was overwhelmed and in total disbelief,” said Creasey. “I didn’t feel like I deserved it.  I was just trying to bring awareness to this issue for other people like myself.” 

Creasey spent 11 years on dialysis after her kidney failed and received a transplant in 2015. Thankfully, the surgery was a success. However, to prevent rejection, Creasey will have to take medication for the rest of her life. She is becoming increasingly concerned about how she is going to pay for her medication after Medicare stops covering the costs in 2018. 

Creasey has been “truly grateful” for what people have given her since the story on NPR. She is enjoying her brand new bed, headboard and frame with sheets, a comforter and some curtains. She is happy to finally make her room a little more like home.  Creaseys says she can now turn her heat down because sleeping on the floor was cold.

“I’m starting off my new year with more faith in people. This experience has touched my heart and I can’t thank everyone enough, “Creasey said.

-Shannon McCarthy

Media Contact

Marianne Worley
Director of Media Relations
Office: 703-558-1287
Pager: 202-405-2824
[email protected]

MedStar Georgetown Ranked #1 in Washington, D.C. Region by U.S. News and World Report

 

(Washington, D.C.) August 3, 2016 - MedStar Georgetown University Hospital has been ranked as the #1 hospital in the Washington, D.C. metropolitan region by U.S. News and World Report in its annual ranking of hospitals nationwide.  “We are very proud of this ranking as it recognizes the dedication and hard work of our more than 5,000 associates who are committed to providing safe, high quality care to our patients and their families,” said Michael Sachtleben, president, MedStar Georgetown University Hospital.

Healthcare is complex and rating hospitals is an intricate process.  There are many organizations that publish hospital rankings, each with its own approach and methodology, and rankings can vary.  While rankings can differ, at MedStar Georgetown one thing that will not waver is our commitment to our mission of providing safe, high-quality care to all of our patients in the spirit of cura personalis, care of the whole person.  We celebrate this recognition with all of our associates with pride and excitement.

Media Contact

Marianne Worley
Director of Media Relations
Office: 703-558-1287
Pager: 202-405-2824
[email protected]

MedStar Georgetown Recognized for Expertise in Treatment of Pancreatic Diseases

 

Washington, D.C. – September 28, 2015 - MedStar Georgetown University Hospital is proud to be one of 30 centers in the United States and the only facility in the Washington, D.C. area, recognized for the care of people with pancreatic diseases by the National Pancreas Foundation. The NPF is a non-profit organization that awards the designation after rigorously reviewing an institution for its focus on multidisciplinary treatment of pancreatitis and treating the “whole person” with a focus on the best possible outcomes and an improved quality of life.

“We are honored to receive the NPF designation and we hope it will help patients suffering with pancreatic disorders find the expertise they need by seeking out NPF centers for their care,” said Nadim Haddad, MD, chief, Gastroenterology at MedStar Georgetown.  “Patients with pancreatic diseases often present with complicated symptoms that require a high level of expertise to correctly diagnose and treat. At MedStar Georgetown we have a comprehensive set of services including the latest technology in pancreatic diagnostics, pain management, the newest treatments for pancreatic cancer, pancreas transplant and now islet cell transplant.”

“The NPF Center designation will help us to better serve this important patient population,” said Matthew Alsante, executive director of the National Pancreas Foundation. “We can recommend with confidence that patients will receive quality care at these designated centers.”

An approved NPF Center has to meet the criteria that were developed by a task force of medical experts and patient advocates. Criteria include having required expert physician specialists like gastroenterologists, pancreas surgeons and interventional radiologists along with patient-focused programs like pain management services, psychosocial support and more. Designated centers also seek to advance research and lead the way for heightened awareness and understanding of pancreatitis and related conditions among community physicians, allied health professionals, patients, families and the general public.

 

About The National Pancreas Foundation

Founded in 1997, the National Pancreas Foundation provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting-edge research, advocating for new and better therapies and providing support and education for patients, caregivers and healthcare professionals. The NPF is the only foundation dedicated to patients suffering from all forms of pancreas disease. For more information visit: www.pancreasfoundation.org.

 

Meet Dr. Nadim Haddad

Media Contact

Marianne Worley
[email protected]
703-558-1287
NPF_Logo

Nursing Studies Aim For Better Patient Care at Medstar Georgetown

(Washington, D.C.) – The Magnet® nurses at MedStar Georgetown University Hospital are conducting studies aimed at improved and even more supportive patient care.

“Nurses often work the closest and the longest hours with our patients, so their input can really make a huge difference,” said Kimberly Groner, MSN, RN, ANP-C, CCRC, NE-BC, director of Professional Practice, Research and Outcomes at MedStar Georgetown.

 “MedStar Georgetown nurses have studied new ways to benefit our patients for many years. I’ve seen nursing research make strides in specialties like transplant, pain management, rheumatologic diseases, cognitive and behavioral therapy, exercise and arthritis.”

One study involves nurses at MedStar Georgetown and their perceptions, comfort and support of advance care planning. On National Healthcare Decisions Day on April 16 Georgetown nurses set up information tables, handed out packets and answered questions from 220 patients and visitors about advance care planning.   Study leaders will use a survey taken by two groups of nurses to gauge whether or not the event influenced their knowledge and perceptions.

“Our nurses want to have the knowledge and comfort to assist patients who need information about advance care planning, “said Groner. “This study will look at whether or not getting involved with an effort to educate the public helps.”

Debra Long, a recent in-patient at MedStar Georgetown discusses her opinions on the video tool study with principal investigator Marlena Fisher, BSN, RN, CCRN
Debra Long, a recent in-patient at MedStar Georgetown discusses her opinions on the video tool study with principal investigator Marlena Fisher, BSN, RN, CCRN

Another study uses a video tool to provide patients and their families with information in laypersons’ terms about cardiopulmonary resuscitation (CPR), life support and patient/family confidence in their decisions about end of life care.  

“Participants take a questionnaire before and after viewing a ten minute video to see if their knowledge on these important topics improves,” said Groner. Our aim is to survey fifty people at first and if we find it helpful, we will make the video a standard practice to include more patients because we will have evidence-based research to prove that it works.”

Debra Long, a recent in-patient at MedStar Georgetown participated in the video tool study administered by principal investigator Marlena Fisher, BSN, RN, CCRN.

Debra Long, a recent in-patient at MedStar Georgetown, participated in the video tool study.
Debra Long views the video tool on about cardiopulmonary resuscitation (CPR), life support, and other subjects related to care.

“I thought the video was very helpful,” said Long.  I was very comfortable watching it and I think others would benefit from the information provided. I have talked with my family members about these very issues.”

“Research has shown that traditional methods to educate patients about CPR and life-sustaining measures haven’t worked very well,” said Fisher. “We want to provide our patients with the terms used by the medical community and see if the video helps them retain the information. Participation in the survey is completely voluntary.”

MedStar Georgetown nurses are also studying the effects of a curriculum whose purpose is to improve the care of the elderly, called NICHE, Nurses Improving Care for Health System Elders.

MedStar Georgetown nurses, who are already NICHE certified are looking at a protocol that could mean a better night’s sleep for some older patients.

“The nurses consulted with physicians and proposed taking patients’ vital signs at 10 p.m. and 6 a.m. instead of midnight and 8 a.m.,” said Groner. We think these might be hours when patients are actually sleeping and we want to determine if this allows for a more restful patient experience. It could be a very simple and practical way to help our patient get better sleep and maybe even heal faster.”

MedStar Georgetown was the first center in Washington, D.C. to achieve prestigious Magnet status back in 2004 by the American Nurses’ Credentialing Center (ANCC) and joins just 71 other institutions, or fewer than seven percent of hospitals nationwide, to be recognized by the Magnet Recognition Program® three times in a row.  The program recognizes healthcare organizations for quality patient care, nursing excellence and innovations in professional nursing practice.

Nurses-National-Healthcare-Decisions-Day-by-M-Worley

 

About MedStar Georgetown University Hospital

MedStar Georgetown University Hospital is a not-for-profit, acute-care teaching and research hospital with 609 beds located in Northwest Washington, D.C. Founded in the Jesuit principle of cura personalis—caring for the whole person—MedStar Georgetown is committed to offering a variety of innovative diagnostic and treatment options within a trusting and compassionate environment.

MedStar Georgetown’s centers of excellence include neurosciences, transplant, cancer and gastroenterology. Along with Magnet® nurses, internationally recognized physicians, advanced research and cutting-edge technologies, MedStar Georgetown’s healthcare professionals have a reputation for medical excellence and leadership. MedStar Georgetown University Hospital—Knowledge and Compassion Focused on You.

 

Media Contact

Marianne Worley
[email protected]
703-558-1287

Georgetown Lombardi Comprehensive Cancer Center Redesignated by National Cancer Institute

Patients Benefit From Access To Oncology’s Leading Experts, Research And Community Outreach

MedStar Georgetown University Hospital is proud to announce that the National Cancer Institute (NCI) has redesignated Georgetown Lombardi Comprehensive Cancer Center as a “comprehensive cancer center.” Georgetown Lombardi has now maintained this designation for the last 21 years and is currently one of only 41 comprehensive cancer centers in the United States.

For cancer patients in the Washington, DC area, this provides confirmation that Georgetown Lombardi is the cancer center of choice, with well-coordinated diagnostics, treatments, clinical trials and research that are on the leading edge of medical science.

“Our designation as a comprehensive cancer center has a direct effect on our community,” explains Dr. Louis M. Weiner, director of Georgetown Lombardi. “Most top oncologists choose to practice at comprehensive cancer centers like ours because it allows them to pursue research that can directly benefit our patients through clinical trials or laboratory discoveries. When someone has cancer, they want the best doctors and cutting-edge treatments. That’s what Georgetown Lombardi offers.”

Technologies like CyberKnife that MedStar Georgetown has used to treat inoperable cancers since 2002 and a proton therapy program to open in 2015 are examples of the cutting-edge care available to patients in the region. MedStar Georgetown will become one of only 13 facilities in the United States to offer the highly advanced proton therapy that precisely targets and destroys cancer cells, sparing healthy cells, reducing side effects, improving patients’ cure rates and reducing the chances of secondary cancers later in life. Proton therapy will be used to treat adults as well as children with cancer.

“The renewal of the National Cancer Institute designation recognizes the invaluable asset the Georgetown Lombardi Comprehensive Cancer Center is to the community we serve both locally and nationally,” said Dr. Richard Goldberg, president of MedStar Georgetown University Hospital and senior vice president of MedStar Health. “As Lombardi’s clinical partner in providing world-class cancer treatment and care to patients across the region, this redesignation further demonstrates the strength of our joint activities in research, community education and outreach. By linking scientific discovery and expert and compassionate patient care, MedStar and Georgetown Lombardi will continue to prevent, treat and help cure cancers.”

Georgetown Lombardi operates two offsite facilities - the Capital Breast Care Center and the Office of Minority Health and Health Disparities Research, both located in Southeast DC that anchor its community-based screening and research efforts among underserved populations. The federal NCI designation as a comprehensive cancer center indicates that Georgetown Lombardi excels in laboratory science, clinical research and population-based programs, along with robust translational research that bridges these areas. It also demonstrates expansive public education and outreach capabilities, which focus on the Washington, DC community.

“This NCI redesignation means that our patients continue to have access to cutting edge treatments, the latest clinical trials and that their care here at MedStar Georgetown is truly patient-centered and comprehensive,” said Dr. John Marshall, chief, Hematology and Oncology at MedStar Georgetown. “Part of being comprehensive means we have multidisciplinary disease teams dedicated to treating their specific cancer. Our faculty members are recognized as national and global leaders in their fields and are an unmatched resource for the patients in our community. Whether one is faced with breast, lung, pancreas, stomach, colorectal or urologic cancer, leukemia, lymphoma, head and neck cancers, sarcomas or pediatric cancers, we provide the team with the most focused expertise in our region. By combining the knowledge of an oncologist, a cancer surgeon, radiation oncologist, nurse navigator and social worker with a variety of support groups and programs like art and music therapy, our patients have all their needs addressed during one of the most difficult times of their lives.”

As Georgetown Lombardi continues to advance cancer care for patients throughout the area, its focus will remain in four specific areas of excellence: cancer prevention and control, breast cancer, experimental therapeutics and molecular oncology. The area of cancer prevention and control received a particularly high rating from NCI reviewers. This program conducts population-based and translational research across the spectrum of cancer control, ranging from early detection to lifestyle intervention to survivorship issues.

Media Contact

Marianne Worley
[email protected]
703-558-1287

Prestigious Magnet® Designation Bestowed to Nursing Program at MedStar Georgetown University Hospital—For the Third Time

American Nurses Credentialing Center Magnet Recognition Program® is an Indicator for Excellence in Patient Care

(Washington, D.C.) – January 9, 2014 - MedStar Georgetown University Hospital proudly announces it has achieved Magnet® designation for the third consecutive time by the American Nurses Credentialing Center (ANCC). MedStar Georgetown joins just 71 other institutions or fewer than seven percent of hospitals nationwide, to be recognized by the Magnet Recognition Program® three times in a row.

MedStar Georgetown was the first hospital in Washington, D.C. to achieve Magnet status back in 2004.

“We are honored to be acknowledged by the ANCC’s Magnet Recognition Program and to achieve this prestigious designation for a third time,” said Richard Goldberg, MD, president of MedStar Georgetown University Hospital. “Our nurses at MedStar Georgetown exhibit the highest of standards when it comes to professionalism and excellence in caring for our patients. I know I join all of my colleagues at MedStar Georgetown in expressing how proud we are to work with them each day and how grateful we are for their role in taking their profession to such a high level of quality and distinction.”

ANCC bestowed its first Magnet designation in 1994 with the idea that the honor would act as a “magnet” for excellence by promoting professionalism in nursing. Magnet recognition is seen as the highest accolade a hospital nursing system can achieve.

A recent study found better patient outcomes in hospitals whose nurses had achieved Magnet recognition. The research results were published in the October 2012 issue of Medical Care, the official journal of the Medical Care section of the American Public Health Association.

“Receiving this national designation by the Magnet Recognition Program points to the excellence of our nurses and all their hard work,” said Eileen Ferrell, MS, BSN, RN, chief nursing officer at MedStar Georgetown. “It means our nurses are high-performing professionals who are committed to delivering extraordinary care to our patients and their families. It also means our nurses are involved in clinical research and performance improvement, all in the best interests of our patients.”

Currently the ANCC asks each institution applying for Magnet status to submit a plan on how the organization will achieve an 80-percent rate of nurses with baccalaureate degree or higher in nursing. This target is consistent with The Institute of Medicine’s report on “The Future of Nursing” which recommends an increase in the number of nurses with baccalaureate degrees to 80-percent by 2020. MedStar Georgetown is proud to have already met this goal with more than 80-percent of our nurses holding a bachelor’s degree or higher in nursing.

Magnet recognition is bestowed upon an organization for a four-year time frame, and an organization that desires to continue to be recognized must re-apply for the designation.

About MedStar Georgetown University Hospital

MedStar Georgetown University Hospital is a not-for-profit, acute-care teaching and research hospital with 609 beds located in Northwest Washington, D.C. Founded in the Jesuit principle of cura personalis—caring for the whole person—MedStar Georgetown is committed to offering a variety of innovative diagnostic and treatment options within a trusting and compassionate environment.

MedStar Georgetown’s centers of excellence include neurosciences, transplant, cancer and gastroenterology. Along with Magnet® nurses, internationally recognized physicians, advanced research and cutting-edge technologies, MedStar Georgetown’s healthcare professionals have a reputation for medical excellence and leadership.

About The American Nurses Credentialing Center’s (ANCC) Magnet Recognition Program®

The Magnet Recognition Program® administered by the American Nurses Credentialing Center (ANCC), the largest and most prominent nurses credentialing organization in the world, recognizes healthcare organizations that provide the very best in nursing care and professionalism in nursing practice. The Magnet Recognition Program serves as the gold standard for nursing excellence and provides consumers with the ultimate benchmark for measuring quality of care. For more information about the Magnet Recognition Program and current statistics, visit www.nursecredentialing.org/magnet.

Media Contact

Marianne Worley
[email protected]
703-558-1287

MedStar Georgetown’s Chief of Breast Surgery, Eleni Tousimis, MD Elected President of the American Medical Women’s Association

(Washington, D.C.) – Dr. Eleni Tousimis, chief of Breast Surgery at MedStar Georgetown University Hospital, has been elected President of the American Medical Women’s Association. The American Medical Women’s Association is the oldest and largest multidisciplinary organization in the country for promoting women’s health issues, mentorship of female physicians and advocacy.

A board certified surgeon, Dr. Tousimis’s special interests are breast surgery, minimally invasive surgery, nipple sparing mastectomy, and intraoperative radiation therapy (IORT). Dr. Tousimis received her medical degree from Albany Medical College and completed training in minimally invasive treatments of breast cancer at Memorial Sloane Kettering Cancer Center in New York City. She was previously Associate Professor of Clinical Surgery at the Weill Cornell Medical College, New York Presbyterian Hospital and served as the Associate Program Director of Surgical Education since 2004.

In addition to AMWA, Dr. Tousimis serves on the leadership council of the International Women’s Health Coalition, the medical advisory board of Women’s Voices for Change and is the section editor of the Aesthetic Plastic Surgery Journal. She has been recognized at Castle Connolly’s Top Doctors, Best Doctors, and has received both teaching awards and the New York Achievement Award for her surgical skills and compassion toward her patients.

About MedStar Georgetown University Hospital

MedStar Georgetown University Hospital is a not-for-profit, acute-care teaching and research hospital with 609 beds located in Northwest Washington, D.C. Founded in the Jesuit principle of cura personalis—caring for the whole person—MedStar Georgetown is committed to offering a variety of innovative diagnostic and treatment options within a trusting and compassionate environment.

MedStar Georgetown’s centers of excellence include neurosciences, transplant, cancer and gastroenterology. Along with Magnet® nurses, internationally recognized physicians, advanced research and cutting-edge technologies, MedStar Georgetown’s healthcare professionals have a reputation for medical excellence and leadership. MedStar Georgetown University Hospital—Knowledge and Compassion Focused on You.

About MedStar Health

MedStar Health combines the best aspects of academic medicine, research and innovation with a complete spectrum of clinical services to advance patient care. As the largest healthcare provider in Maryland and the Washington, D.C., region, MedStar’s 10 hospitals, the MedStar Health Research Institute and a comprehensive scope of health-related organizations are recognized regionally and nationally for excellence in medical care. MedStar has one of the largest graduate medical education programs in the country, training more than 1,100 medical residents annually, and is the medical education and clinical partner of Georgetown University. MedStar Health is a $4.5 billion not-for-profit, regional healthcare system based in Columbia, Maryland, and one of the largest employers in the region. Its almost 30,000 associates and 6,000 affiliated physicians all support MedStar Health’s Patient First philosophy that combines care, compassion and clinical excellence with an emphasis on customer service.

Media Contact

Marianne Worley
703-558-1287
[email protected]

Patient Contact: 202-342-2400